Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
19%
OVERLAP
BY WEIGHT
BY WEIGHT
23
# OF OVERLAPPING HOLDINGS
XBI
119
HOLDINGS
20%
ALSO IN CANC
CANC
48
HOLDINGS
48%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 2.6% | 4.1% | 2.6% |
|
AMGEN INC | 2.3% | 3.3% | 2.3% |
|
BRIDGEBIO PHARMA, INC. | 2.2% | 4.9% | 2.2% |
|
ABBVIE INC | 2.3% | 1.8% | 1.8% |
|
REVOLUTION MEDICINES, INC. | 1.4% | 4.9% | 1.4% |
XBI Overweight Relative to CANC
|
ALNYLAM PHARMACEUTICALS INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.5% |
|
INSMED INC | 2.5% |
|
NEUROCRINE BIOSCIENCES INC | 2.5% |
|
NATERA INC | 2.4% |
|
INCYTE CORP | 2.4% |
|
MODERNA, INC. | 2.4% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
|
HALOZYME THERAPEUTICS INC | 2.4% |
|
BIOMARIN PHARMACEUTICAL INC | 2.3% |
XBI Underweight Relative to CANC
 |
ROCHE HOLDINGS LTD-SPONS ADR | -5.3% |
|
ELI LILLY & CO | -5.2% |
|
NOVARTIS AG | -4.4% |
 |
ASTRAZENECA PLC | -4.1% |
 |
MERUS N.V. | -3.8% |
 |
GENMAB A/S SPONSORED ADR | -3.7% |
|
BRISTOL-MYERS SQUIBB CO | -3.5% |
|
REVOLUTION MEDICINES, INC. | -3.4% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.7% |